As of November 2024, Samsung Biologics has a market cap of $53.12B. This makes Samsung Biologics the world's 326th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $44.05B | 8.03% |
2023 | $40.78B | -7.43% |
2022 | $44.05B | -9.08% |
2021 | $48.45B | 9.32% |
2020 | $44.32B | 90.76% |
2019 | $23.23B | 12.03% |
2018 | $20.74B | 4.18% |
2017 | $19.91B | 145.70% |
2016 | $8.10B | - |